doi: 10.4161/psb.6.6.15147 24 GhantaS.DattaR.BhattacharyyaD.SinhaR.KumarD.HazraS.et al
Established in Hyderabad, India in 1978, Gland Pharma has grown over the years from a contract manufacturer [HK1] of small volume liquid parenteral products, to become one of the largest and fastest growing generic injectables manufacturing companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets
MMPs affect some clinicopathological conditions, including kidney diseases
Com 48 doses por embalagem, a X-Carnitine oferece mais que o triplo de pores de alguns concorrentes lquidos que entregam apenas 13 a 16 doses
D.MontineT
Glucagon-like peptide-1 (GLP-1) therapies have become a breakthrough in appetite control and insulin secretion